Consequently, it is likely that SRSF3 presents low expression and tumor-suppressor activity in mouse liver disease, while it shows high expression and acts as an oncogene in human HCC, suggesting its role as an unfavorable prognostic predictor in HCC. The gene discussed is SRSF3; the disease is hepatocellular carcinoma.